“…Archetypal examples include Cp CaI(thf) n (Cp = C 5 Me 5 or C 5 Me 4 Et) complexes, which undergo Schlenk-type rearrangement in THF solution to form 2:1:1 mixtures of Cp CaI(thf) n , Cp 2 Ca, and CaI 2 , respectively [7,8]. The position of equilibrium can be shifted somewhat by the solvent (aromatic solvents favor the heteroleptic species) and by the use of "encapsulating" cyclopentadienyl rings such C 5 (i-Pr) 4 H (=Cp 4i ) [1,3], C 5 (SiMe 3 ) 3 H 2 (=Cp 3Si ) [2] and C 5 (t-Bu) 3 H 2 [9], which sterically interfere with the rearrangement process. The identity of the X ligand in Cp CaX complexes also affects the position of Schlenk equilibrium, and the present work demonstrates how the use of aryloxide ligands can make possible the isolation of rearrangement-resistant complexes in the absence of encapsulating Cp rings or with easily displaceable Cp rings such as Cp 3Si .…”